Cycloserine
FDA Label NDC 13845-1202

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Parsolex Gmp Center, Inc. for the product Cycloserine (NDC 13845-1202). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding blister pack carton, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Blister Pack Carton

Panels for the blister pack carton

Blister Pack Carton (Cycloserine (13845 1202 2) Blister Pack Artwork)

Blister Pack Carton (Cycloserine (13845 1202 2) Blister Pack Artwork)

* Please review the disclaimer below.